(S)-6-METHYL-2,3-DIHYDRO-1H-INDEN-1-AMINE HCL, 95.0%, 250mg

Larotrectinib, 97%, 5g

2-Bromo-5-fluoroisonicotinic acid, 95.0%, 500g

N-(tert-Butoxycarbonyl)-N-methyl-L-alanine>98.0%(GC)(T)25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiazol-4-yl)propanoic acid, 97.0%, 10g

(S)-1-(2-fluoro-3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 97%, 100mg

2,4-Dichloro-3-fluorobromobenzene, 97.0%, 1g

(4-Bromophenyl)acetaldehyde, 95.0%, 100mg

Tetra-n-butylammonium trifluoromethanesulfonate, 99.0%, 5g

3,4-Difluorophenylacetic acid, 99.0%, 10g

Tris(4-methoxyphenyl)phosphine, 95.0%, 1g

4-(1,3-dioxolan-2-ylmethyl)-1-ethoxybenzene, 97.0%, 1g

Methyl (2-imino-1,3-thiazolidin-3-yl)acetate hydrobromide, 95.0%, 250mg